ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Clinical Cardiac Electrophysiology

Top Clinical Cardiac Electrophysiology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RONALD WALSH D.O.

Clinical Cardiac Electrophysiology

5,613

$311K

594
518 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

2%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $72

AHMET GURSOY M.D.

Clinical Cardiac Electrophysiology

4,259

$337K

639
608 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 25%

$79
Average prescription price

Avg: $72

THABET ALSHEIKH MD

Clinical Cardiac Electrophysiology

4,230

$216K

567
478 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $72

ARNE SIPPENS GROENEWEGEN MD

Clinical Cardiac Electrophysiology

4,006

$241K

509
453 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $72

GABRIEL BREUER M.D.

Clinical Cardiac Electrophysiology

3,992

$358K

450
423 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 25%

$90
Average prescription price

Avg: $72

JAMES WALSH MD

Clinical Cardiac Electrophysiology

3,955

$151K

578
495 are 65+

21%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

10%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $72

MARILYN COX M.D.

Clinical Cardiac Electrophysiology

3,867

$253K

454
393 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $72

PETER GARCIA MD

Clinical Cardiac Electrophysiology

3,518

$105K

884
838 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 25%

$30
Average prescription price

Avg: $72

EFRAIN GONZALEZ M.D.

Clinical Cardiac Electrophysiology

3,229

$318K

359
329 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 25%

$99
Average prescription price

Avg: $72

JONATHAN HOBSON M.D.

Clinical Cardiac Electrophysiology

3,022

$188K

419
379 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $72

FARHAT KHAIRALLAH M.D.

Clinical Cardiac Electrophysiology

2,989

$277K

411
343 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 25%

$93
Average prescription price

Avg: $72

ANTHONY MAGNANO MD

Clinical Cardiac Electrophysiology

2,954

$246K

398
347 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $72

JOHN NORRIS M.D.

Clinical Cardiac Electrophysiology

2,835

$334K

377
351 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $72

JAY PATTERSON MD

Clinical Cardiac Electrophysiology

2,775

$179K

426
368 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $72

JOSE MARTEL MD

Clinical Cardiac Electrophysiology

2,364

$168K

309
281 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $72

SUMIT VERMA MD

Clinical Cardiac Electrophysiology

2,309

$183K

385
324 are 65+

19%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 25%

$79
Average prescription price

Avg: $72

PETER TAYLOR MD

Clinical Cardiac Electrophysiology

2,232

$109K

335
242 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $72

NAUSHAD SHAIK MD

Clinical Cardiac Electrophysiology

2,223

$106K

450
383 are 65+

20%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $72

NADIM KHAN M.D.

Clinical Cardiac Electrophysiology

2,196

$163K

351
310 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $72

SAUMIL OZA M.D.

Clinical Cardiac Electrophysiology

2,134

$174K

313
268 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 25%

$81
Average prescription price

Avg: $72

DINESH PUBBI M.D.

Clinical Cardiac Electrophysiology

2,112

$90.5K

341
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $72

DAVID BELLO M.D.

Clinical Cardiac Electrophysiology

2,007

$124K

309
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $72

ROBERT SHEPPARD M.D.

Clinical Cardiac Electrophysiology

1,966

$157K

255
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 25%

$80
Average prescription price

Avg: $72

PHILIP ZILO M.D.

Clinical Cardiac Electrophysiology

1,947

$144K

295
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $72

KENNETH YAMAMURA MD

Clinical Cardiac Electrophysiology

1,825

$224K

285
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 25%

$123
Average prescription price

Avg: $72

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank